Cargando…
A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
BACKGROUND: There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to obtain 95...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183116/ https://www.ncbi.nlm.nih.gov/pubmed/32346486 http://dx.doi.org/10.1186/s40814-020-00594-1 |